Skip to main content
Europlasma logo

Europlasma — Investor Relations & Filings

Ticker · ALEUP ISIN · FR001400CF13 LEI · 969500WYVNHBV1ABQ250 Euronext Growth Water supply; sewerage, waste management and remediation activities
Open in API
Filings indexed 504 across all filing types
Latest filing 2025-01-22 Capital/Financing Update
Country FR France
Listing Euronext Growth ALEUP

About Europlasma

https://www.europlasma.com/en/

Europlasma is a company specializing in clean technology and energy solutions. Its core activities focus on the research, engineering, and application of plasma solutions for industrial purposes, particularly for the treatment of hazardous waste and gas. The company provides services for the destruction and valorization of asbestos waste. In the decarbonization sector, Europlasma transforms waste into Solid Recovered Fuel (SRF). Additionally, the company operates an industrial division that manufactures hollow bodies and anodized sheets for capacitors.

Recent filings

Filing Released Lang Actions
EUROPLASMA: Tirage de 400 obligations convertibles en actions nouvelles pour un montant nominal de 2M€
Capital/Financing Update Classification · 98% confidence The document is a press release ("Communiqué de presse") dated January 22, 2025, announcing the drawdown ("tirage") of convertible bonds (Obligations Convertibles en Actions - OCA) for a nominal amount of 2 million euros. This action relates to a financing program previously established with Environmental Performance Financing (EPF). The text details the context, use of funds (financing growth, acquisitions, and investments), legal framework (referencing prior general meetings and delegations), and extensively discusses the associated risks, particularly dilution and share price pressure resulting from the potential conversion of these instruments into new shares. This content directly concerns fundraising, capital structure changes, and the issuance of debt convertible into equity. This aligns perfectly with the definition of 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a simple dividend notice (DIV).
2025-01-22 French
EUROPLASMA: Information relative au nombre total de droits de vote et d’actions composant le capital au 31 décembre 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a press release dated January 6, 2025, titled 'Information relative au nombre total de droits de vote et d'actions composant le capital au 31 décembre 2024' (Information relative to the total number of voting rights and shares comprising the capital as of December 31, 2024). It explicitly states the total number of shares and voting rights as required by French commercial code (L. 233-8 II) and AMF regulations (223-16). This type of periodic disclosure regarding the total number of shares and voting rights is a standard regulatory filing, often related to capital structure updates or required periodic reporting. Since it is a specific regulatory disclosure about the capital structure (shares and voting rights) and not a general announcement of a report (RPA) or a broad miscellaneous filing (RNS), it fits best under Capital/Financing Update (CAP) or potentially a specific regulatory filing category. Given the options, 'CAP' covers capital structure changes, and 'SHA' covers share issues. However, this is a mandatory disclosure of the *current* count, not an issuance or buyback. In many contexts, mandatory periodic disclosures about share count fall under general regulatory reporting. Since there isn't a specific code for 'Total Voting Rights Disclosure', and it relates directly to the capital structure, 'CAP' is a possibility, but 'RNS' (Regulatory Filings - fallback) is often used for mandatory, non-financial periodic disclosures that don't fit elsewhere. Looking closely at the definitions, 'SHA' is for 'Share Issue/Capital Change'. This document reports the *status* of the capital, not a change event itself, although it is related. The most appropriate general category for mandatory regulatory disclosures not covered elsewhere is RNS. However, the content is highly specific to the number of shares and voting rights, which is a key component of capital structure reporting. Given the options, and recognizing this as a mandatory regulatory disclosure about the share base, I will classify it as 'RNS' as it is a specific, periodic regulatory update that doesn't fit the other specific financial report types, though it touches upon capital structure elements.
2025-01-06 French
EUROPLASMA: Obtention d’une nouvelle licence export vers la République tchèque
Regulatory Filings Classification · 100% confidence The document is titled "Communiqué de presse" (Press Release) dated December 11, 2024, announcing a specific operational event: "Obtention d'une nouvelle licence export vers la République tchèque" (Obtaining a new export license to the Czech Republic). This is a specific, timely announcement regarding business operations (defense contracts/exports) rather than a comprehensive periodic report (like 10-K or IR), a formal shareholder vote result (DVA), or a management change (MANG). Since it is a press release announcing a significant business development, it fits best under the general category for regulatory announcements or press releases that don't fit a more specific operational code. Given the options, 'RNS' (Regulatory Filings / General regulatory announcements) is the most appropriate fallback for a standard press release detailing a business update, although 'LTR' (Legal Proceedings Report) or 'TAR' (M&A Activity) are clearly incorrect. It is not an Earnings Release (ER) as it does not discuss financial results. Therefore, RNS is the best fit as a general regulatory/news announcement.
2024-12-11 French
EUROPLASMA: Information relative au nombre total de droits de vote et d’actions composant le capital au 30 novembre 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a press release dated December 5, 2024, titled "Information relative au nombre total de droits de vote et d'actions composant le capital au 30 novembre 2024" (Information relating to the total number of voting rights and shares comprising the capital as of November 30, 2024). It explicitly states the total number of shares and voting rights as required by French commercial code (L. 233-8 II) and AMF regulations (223-16). This type of periodic disclosure regarding the total share capital and voting rights is a standard regulatory filing, but it does not fit perfectly into the major categories like 10-K, ER, or IR. It is a specific regulatory announcement concerning the capital structure. Given the options, it is a notification about the capital structure and voting rights. While there isn't a perfect match for 'Total Share Capital Disclosure', it is most closely related to announcements concerning capital changes or major shareholding notifications. Since it is a mandatory disclosure about the total number of shares/votes, and not a change in ownership (MRQ) or a share issue (SHA/POS), it falls best under the general regulatory announcement category, RNS, or potentially SHA if interpreted broadly as a capital structure update. However, since it is a routine, periodic disclosure of the total count, and not a transaction, RNS (Regulatory Filings) is the most appropriate fallback for specific, non-core reporting disclosures that don't fit elsewhere. The document length is short (2742 chars), but it is the report itself, not an announcement of a report, so RPA is not applicable. It is a specific regulatory disclosure, thus RNS is chosen as the best fit among the provided codes for mandatory, non-financial/non-meeting related disclosures.
2024-12-05 French
EUROPLASMA: Le Tribunal de commerce de Tours valide la reprise de FP Environnement
Legal Proceedings Report Classification · 99% confidence The document is a press release ("Communiqué de presse") dated November 29, 2024, announcing that the Commercial Court of Tours validated the takeover bid by Europlasma for FP Environnement. This announcement details a significant corporate transaction involving the acquisition of another company (FP Environnement) by Europlasma. This type of event, concerning mergers, acquisitions, or takeover bids, directly corresponds to the definition of M&A Activity (TAR). It is not an Annual Report (10-K), an Earnings Release (ER), or an Interim Report (IR) as it focuses on a legal/transactional event rather than periodic financial performance reporting. It is too specific to be a general Regulatory Filing (RNS) and is clearly about a takeover/acquisition proposal being validated.
2024-11-29 French
EUROPLASMA: Information relative au nombre total de droits de vote et d’actions composant le capital au 31 octobre 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a press release dated November 8, 2024, titled "Information relative au nombre total de droits de vote et d'actions composant le capital au 31 octobre 2024" (Information relating to the total number of voting rights and shares comprising the capital as of October 31, 2024). It explicitly states the total number of shares and voting rights as required by French commercial code (L. 233-8 II) and AMF regulations (223-16). This type of mandatory disclosure regarding the total number of shares/voting rights is a specific regulatory filing requirement, often related to capital structure transparency. While it is a press release, its core content is a formal declaration of share capital figures. This fits best under the general category for regulatory announcements that aren't covered by more specific forms like 10-K, ER, or DIV. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for this type of mandatory, periodic capital structure disclosure that doesn't map directly to the other specific codes (like DIRS, SHA, or POS, which deal with transactions or changes, not just the periodic count). However, since the document is a formal declaration of capital structure figures, it is a specific type of regulatory disclosure. If a more specific code existed for 'Share Capital Count Disclosure', that would be ideal. Comparing the definitions, it is not an AGM-R, 10-K, ER, or IR. It is not a transaction (POS/SHA). It is a formal regulatory update. RNS is the best fit as a general regulatory announcement.
2024-11-08 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.